In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-Granulocyte-macrophage and CFU-megakaryocyte): Evidence for possible biologic differences between mobilized blood and bone marrow

被引:4
|
作者
Scheding, S [1 ]
Media, JE [1 ]
KuKuruga, MA [1 ]
Nakeff, A [1 ]
机构
[1] WAYNE STATE UNIV, SCH MED, DIV HEMATOL & ONCOL, DETROIT, MI 48201 USA
关键词
D O I
10.1182/blood.V88.2.472.bloodjournal882472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increasing evidence especially stemming from peripheral blood progenitor transplantation studies points to a possible biologic difference between mobilized blood and bone marrow progenitor cells. The objective of this study was to compare the in situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor (rhG-CSF)-recruited circulating granulopoietic (blood colony-forming unit-granulocyte-macrophage [CFU-GM(blood)]) and megakaryocytopoietic (blood CFU-megakaryocyte [CFU-Meg(blood)]) progenitors, with the nonmobilized fraction remaining in the bone marrow (CFU-GM(femur) and CFU-Meg(femur)). Splenectomized male B6D2F1 mice received 50 mu g/kg/d rhG-CSF daily for 8 days to induce high levels of circulating progenitors, followed by either total body X-irradiation (TBI) or X-irradiation of the chest (CI) with 62.5, 125, 250, or 500 cGy. Progenitor cells were assayed 24 hours after irradiation. circulating CFU-GM and CFU-Meg in the blood were decreased in a dose-dependent fashion by both TBI and CI, with TBI causing greater damage than CI. Average D-0 values for TBI were 53 cGy for CFU-GM(blood) and 40 cGy for CFU-Meg(blood) D-0 values for Ci were 90 cGy for CFU-GM(blood) and 140 cGy for CFU-Meg(blood). As seen for blood progenitor cells, TBI caused a dose-dependent decrease of both CFU-GM(femur) (D-0, 136 cGy) and CFU-Meg(femur) (D-0 148 cGy). However, radiation-induced bone marrow progenitor cell kill was significantly lower when compared with blood progenitors. Despite the fact that circulating blood elements only received a fraction of the total dose administered as CI, the extent of blood progenitor kill caused by CI was higher than the effects of identical TBI doses on bone marrow CFU. The results of this study showed that rhG-CSF-recruited CFU-Meg(blood) and CFU-GM(blood) were considerably more radiosensitive than femoral progenitors, thereby providing novel evidence for a biologic difference between rhG-CSF-recruited peripheral blood progenitors and the nonrecruited bone marrow CFU. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY
    PETERS, WP
    ROSNER, G
    ROSS, M
    VREDENBURGH, J
    MEISENBERG, B
    GILBERT, C
    KURTZBERG, J
    BLOOD, 1993, 81 (07) : 1709 - 1719
  • [32] Differential effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on the radiation sensitivity of normal versus leukemic bone marrow progenitor cell populations
    Waddick, KG
    ChandanLanglie, M
    Uckun, FM
    LEUKEMIA & LYMPHOMA, 1997, 25 (1-2) : 77 - 90
  • [33] Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma
    Colombat, P
    Delain, M
    Desbois, I
    Domenech, J
    Binet, C
    Tabah, I
    Lamagnere, JP
    Linassier, C
    BONE MARROW TRANSPLANTATION, 1996, 18 (02) : 293 - 299
  • [34] Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells
    Na, Yi Rang
    Hong, Ji Hye
    Lee, Min Yong
    Jung, Jae Hun
    Jung, Daun
    Kim, Young Won
    Son, Dain
    Choi, Murim
    Kim, Kwang Pyo
    Seok, Seung Hyeok
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (10) : 2722 - 2732
  • [35] A CASE OF FELTYS SYNDROME WITH EVIDENCE FOR SUPPRESSION OF HUMAN-BONE MARROW COLONY-FORMING UNIT IN CULTURE (CFU-C)-DERIVED COLONY FORMATION BY PATIENTS PERIPHERAL-BLOOD LYMPHOCYTE-T
    SUGIMOTO, M
    WAKABAYASHI, Y
    SHIOKAWA, Y
    TAKAKU, F
    ACTA HAEMATOLOGICA JAPONICA, 1984, 47 (07): : 1445 - 1455
  • [36] Application of peripheral blood stem cells (PBSC) mobilized by recombinant human granulocyte colony stimulating factor for allogeneic PBSC transplantation and the comparison of allogeneic PBSC transplantation and bone marrow transplantation
    Kasai, M
    Kiyama, Y
    Kawamura, A
    TRANSFUSION AND APHERESIS SCIENCE, 2002, 26 (02) : 121 - 127
  • [37] LONG-TERM FOLLOW-UP OF 103 PATIENTS WHO RECEIVED RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER UNRELATED DONOR BONE-MARROW TRANSPLANTATION
    NEMUNAITIS, J
    ANASETTI, C
    BUCKNER, CD
    APPELBAUM, FR
    SHANNONDORCY, K
    HANSEN, J
    SINGER, JW
    BLOOD, 1993, 81 (03) : 865 - 865
  • [38] RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED NON-HODGKINS-LYMPHOMA - BLOOD AND BONE-MARROW PROGENITOR GROWTH-STUDIES - A PHASE-II EASTERN COOPERATIVE ONCOLOGY GROUP TRIAL
    LAZARUS, HM
    ANDERSEN, J
    CHEN, MG
    VARIAKOJIS, D
    MANSOUR, EG
    OETTE, D
    ARCE, CA
    OKEN, MM
    GERSON, SL
    BLOOD, 1991, 78 (03) : 830 - 837
  • [39] RECOMBINANT HUMAN NONGLYCOSYLATED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-III CLINICAL-TRIAL
    HIRAOKA, A
    MASAOKA, T
    MIZOGUCHI, H
    ASANO, S
    KODERA, Y
    KITAMURA, K
    TAKAKU, F
    KOMEMUSHI, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1994, 24 (04) : 205 - 211
  • [40] LONG-TERM FOLLOW-UP OF A PHASE-III STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCIES
    RABINOWE, SN
    NEUBERG, D
    BIERMAN, PJ
    VOSE, JM
    NEMUNAITIS, J
    SINGER, JW
    FREEDMAN, AS
    MAUCH, P
    DEMETRI, G
    ONETTO, N
    GILLIS, S
    OETTE, D
    BUCKNER, D
    HANSEN, JA
    RITZ, J
    ARMITAGE, JO
    NADLER, LM
    APPELBAUM, FR
    BLOOD, 1993, 81 (07) : 1903 - 1908